Physician
Endocrinology
Dr. Sreenija Suryadevara, MD
Sreenija Suryadevara works in the field of Endocrinology. He went to Siddhartha Medical College NTR. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Sreenija Suryadevara is a published physician. He published 8 publications, including: 'Type and prevalence of adverse events during the parenteral nutrition cycling process in patients being prepared for discharge.' Sreenija Suryadevara accepts all Medicare patients.
Publications
Conditions Treated
- Adrenal Incidentaloma
- Adrenal Insufficiency
- Diabetes Type 1
- Diabetes Type 2
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Pathway X Bronze Direct CACA IN HIX
- Blue Card PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- HealthSmart
- Choice Care PPO
- Kaiser Permanente
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Paramount
- POMCO Group
- Tricare
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
- Wells Fargo Insurance
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Dartmouth-Hitchcock Medical Center
-
Siddhartha Medical College NTR
Drug Facts
NPI NUMBER |
|
1073832564 |
NPPES Provider LastName |
|
SURYADEVARA |
NPPES Provider FirstName |
|
SREENIJA |
NPPES Provider ZIPCode |
|
037561000 |
NPPES Provider State |
|
NH |
Specialty Description |
|
Internal Medicine |
Total Claim Count |
|
304.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1073832564 |
Last Name Of The Provider |
SURYADEVARA |
First Name Of The Provider |
SREENIJA |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog